Arcoma AB Asset Resilience Ratio
Arcoma AB asset resilience ratio. Arcoma AB (ARCOMA) has an Asset Resilience Ratio of 18.92% as of March 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Arcoma AB to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Arcoma AB (None–None)
Asset resilience ratio of Arcoma AB from None to None. This chart shows how Arcoma AB's Asset Resilience Ratio has changed over time. Read debt load of Arcoma AB for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Arcoma AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ARCOMA total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr14.41 Million | 18.92% |
| Total Liquid Assets | Skr14.41 Million | 18.92% |
Asset Resilience Insights
- Good Liquidity Position: Arcoma AB maintains a healthy 18.92% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Arcoma AB Industry Peers by Asset Resilience Ratio
Compare Arcoma AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Arcoma AB Asset Resilience Ratio by Year (None–None)
Arcoma AB asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Arcoma AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more